Analyst Ratings for ransCode Therapeutics Inc (RNAZ)

RNAZ Rating Summary

  |   Expand Research on RNAZ
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/7/2022 H.C. Wainwright
» Updated 4/16/2025
Emily Bodnar New Coverage Buy
(N/A)
10.00
(20.00)
1.76
(9.60)
445.45% Details